» Authors » Takashi Ishiguro

Takashi Ishiguro

Explore the profile of Takashi Ishiguro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 170
Citations 1162
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Onodera Y, Ishiguro T, Uozumi R, Isono T, Nishida T, Kobayashi Y, et al.
Intern Med . 2025 Jan; PMID: 39756876
Objective Community-acquired pneumonia is an acute infectious disease with potentialy life-threatening consequences. Because invasive mechanical ventilation (IMV) requires the attention of many medical staff, early risk prediction at the time...
2.
Takaoka H, Kawada I, Hiruma G, Nagashima K, Terai H, Ishida N, et al.
BMJ Open Respir Res . 2024 Dec; 11(1. PMID: 39721744
Objectives: Severe acute respiratory syndrome coronavirus 2 significantly impacts Japan with a high number of infections and deaths reported. Long coronavirus disease (COVID) characterised by persistent symptoms after COVID-19 has...
3.
4.
Isono T, Kojima A, Nishida T, Kobayashi Y, Ishiguro T, Takaku Y, et al.
Intern Med . 2024 Nov; 64(3):367-374. PMID: 39566990
Objective Thymus and activation-regulated chemokine (TARC) can predict severe disease in patients with coronavirus disease 2019 (COVID-19). However, no reports have addressed the predictive value of TARC with the widespread...
5.
Kobayashi Y, Ishiguro T, Kagiyama N, Sumi M, Takayanagi N
J Clin Med . 2024 Oct; 13(20). PMID: 39458197
Pulmonary diseases are common in patients with thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Although high prevalences of chronic obstructive pulmonary disease and lung cancer (LC) are known,...
6.
Shimoda M, Tanaka Y, Ohe T, Ishiguro T, Suzuki A, Kurahara Y, et al.
Respir Investig . 2024 Aug; 62(6):963-969. PMID: 39186880
Introduction: Adenosine deaminase (ADA) in pleural fluid is a useful marker for diagnosing tuberculous pleurisy. However, recent studies have reported a lower specificity of pleural fluid ADA levels. We previously...
7.
Isono T, Furuno H, Onodera Y, Maruyama T, Takeuchi Y, Kojima A, et al.
Respir Investig . 2024 Aug; 62(6):951-959. PMID: 39186878
Background: Proton pump inhibitors (PPIs) are reported to decrease the efficacy of immune checkpoint inhibitors (ICIs), but there are few reports on the association between ICI efficacy and antacids other...
8.
Ishiguro T
Intern Med . 2024 Apr; 63(24):3405-3406. PMID: 38631851
No abstract available.
9.
Hattori S, Oguma T, Ishiguro T, Suzuki J, Fukunaga K, Shimoda T, et al.
Mycoses . 2024 Feb; 67(2):e13705. PMID: 38369597
Background: High-attenuation mucus (HAM) is a specific manifestation of allergic bronchopulmonary mycosis (ABPM) on chest computed tomography (CT). Objectives: To compare the diagnostic accuracy of the two definitions of HAM...
10.
Oguma T, Ishiguro T, Kamei K, Tanaka J, Suzuki J, Hebisawa A, et al.
Clin Transl Allergy . 2024 Jan; 14(1):e12327. PMID: 38282191
Background: Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune, a basidiomycete fungus, is one of the most...